CEL-SCI Corporation
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from CEL-SCI Corporation's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Net Worth Ratio: Of every $100 of net worth, $99 is tangible; the rest is goodwill and other intangibles, often from buying other companies. More tangible than 93% of Healthcare companies in United States.
- Tangible Assets Ratio: Of every $100 the company owns, $100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. More tangible than 93% of Healthcare companies in United States.
- Shareholder Slice Ratio: Share count rose 453% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than 85% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
-113.4×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 83% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 3/3Sales grew in 0 of the last 3 years; profit grew in 3 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-7.0×Operating cash was negative last year, while some debt falls due within a year.
Higher than 56% of Healthcare companies in United States.
Cash Cushion Ratio
+6%Cash, after subtracting all debt, equals 6% of its market value (net cash).
Lower than 56% of Healthcare companies in United States.
Tangible Assets Ratio
100%Of every $100 the company owns, $100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 93% of Healthcare companies in United States.
Tangible Net Worth Ratio
99%Of every $100 of net worth, $99 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 93% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
CEL-SCI Corporation made a loss over the last year. CEL-SCI Corporation owes $0.49 for every $1 it owns. CEL-SCI Corporation made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Sep 2025.
P/E ratio
LossCEL-SCI Corporation made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
2.58The share price is 2.58 times CEL-SCI Corporation's book value per share, higher than 50% of Healthcare companies in United States.
Market cap
$28 MThe total market value of all of CEL-SCI Corporation's shares at today's price (share price × number of shares), smaller than 80% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$11 MWhat CEL-SCI Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.62Net worth divided by the number of shares. The share price of $1.61 is 2.6 times this, which is the P/B above.
Return on equity (ROE)
-252.5%CEL-SCI Corporation lost 252.5% of its shareholders' money over the last year, lower than 88% of Healthcare companies in United States.
Owes vs Owns
0.49×CEL-SCI Corporation owes $0.49 for every $1 it owns (low), higher than 54% of Healthcare companies in United States.
Dividend yield
NoneCEL-SCI Corporation does not currently pay a dividend.
Profit growth
LossCEL-SCI Corporation made a loss in each of the last two years.
Interest cover
Not coveredCEL-SCI Corporation's operating profit did not cover its interest costs in the year to Sep 2025.
Cash vs debt
Net cashCEL-SCI Corporation held $2 M more cash than debt (net cash) at Sep 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For CEL-SCI Corporation: $28 M ÷ $11 M (30 Jun 2026) = 2.6.
What is CEL-SCI Corporation's return on equity?
CEL-SCI Corporation lost 252.5% of its shareholders' money over the last year, lower than 88% of Healthcare companies in United States.
How much does CEL-SCI Corporation owe compared with what it owns?
CEL-SCI Corporation owes $0.49 for every $1 it owns (low), higher than 54% of Healthcare companies in United States.
Does CEL-SCI Corporation pay a dividend?
No. CEL-SCI Corporation does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.